Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2026-01-02 @ 6:24 AM
Study NCT ID:
NCT01803035
Status:
COMPLETED
Last Update Posted:
2014-04-28
First Post:
2013-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
Sponsor:
Lytix Biopharma AS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-21
First Submit QC Date:
None
Study First Post Date:
2013-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-25
Last Update Post Date:
2014-04-28
Last Update Post Date Type:
ESTIMATED